Search details
1.
Next generation sequencing of high-grade adult-type diffuse glioma in the Netherlands: interlaboratory variation in the primary diagnostic and recurrent setting.
J Neurooncol
; 166(3): 485-492, 2024 Feb.
Article
in English
| MEDLINE | ID: mdl-38285243
2.
BRCA1/2 testing rates in epithelial ovarian cancer: a focus on the untested patients.
Int J Gynecol Cancer
; 33(8): 1260-1269, 2023 08 07.
Article
in English
| MEDLINE | ID: mdl-37137525
3.
Multicenter Comparison of Molecular Tumor Boards in The Netherlands: Definition, Composition, Methods, and Targeted Therapy Recommendations.
Oncologist
; 26(8): e1347-e1358, 2021 08.
Article
in English
| MEDLINE | ID: mdl-33111480
4.
Comprehensive routine diagnostic screening to identify predictive mutations, gene amplifications, and microsatellite instability in FFPE tumor material.
BMC Cancer
; 20(1): 291, 2020 Apr 07.
Article
in English
| MEDLINE | ID: mdl-32264863
5.
A case report of an unusual non-mucinous papillary variant of CPAM type 1 with KRAS mutations.
BMC Pulm Med
; 20(1): 52, 2020 Feb 24.
Article
in English
| MEDLINE | ID: mdl-32093717
6.
Diagnosis and Treatment Monitoring of a Patient with Gastrointestinal Stromal Tumor by Next-Generation Sequencing and Droplet Digital Polymerase Chain Reaction Assay of a PDGFRA Mutation in Plasma-Derived Cell-Free Tumor DNA.
Oncologist
; 24(6): e387-e390, 2019 06.
Article
in English
| MEDLINE | ID: mdl-30670599
7.
Kinase activity profiling reveals active signal transduction pathways in pediatric acute lymphoblastic leukemia: a new approach for target discovery.
Proteomics
; 15(7): 1245-54, 2015 Apr.
Article
in English
| MEDLINE | ID: mdl-25422122
8.
Vascular endothelial growth factor signaling in acute myeloid leukemia.
Cell Mol Life Sci
; 70(8): 1307-17, 2013 Apr.
Article
in English
| MEDLINE | ID: mdl-22833169
9.
Osimertinib and palbociclib in an EGFR-mutated NSCLC with primary CDK4 amplification after progression under osimertinib.
NPJ Precis Oncol
; 8(1): 113, 2024 May 22.
Article
in English
| MEDLINE | ID: mdl-38778166
10.
BRCA1/2 Testing Landscape in Ovarian Cancer: A Nationwide, Real-World Data Study.
Cancers (Basel)
; 16(9)2024 Apr 26.
Article
in English
| MEDLINE | ID: mdl-38730634
11.
Levels of circulating tumor DNA correlate with tumor volume in gastro-intestinal stromal tumors: an exploratory long-term follow-up study.
Mol Oncol
; 2024 May 24.
Article
in English
| MEDLINE | ID: mdl-38790141
12.
High VEGFC expression is associated with unique gene expression profiles and predicts adverse prognosis in pediatric and adult acute myeloid leukemia.
Blood
; 116(10): 1747-54, 2010 Sep 09.
Article
in English
| MEDLINE | ID: mdl-20522712
13.
High dose osimertinib in patients with advanced stage EGFR exon 20 mutation-positive NSCLC: Results from the phase 2 multicenter POSITION20 trial.
Lung Cancer
; 170: 133-140, 2022 08.
Article
in English
| MEDLINE | ID: mdl-35777160
14.
Actionability of on-target ALK Resistance Mutations in Patients With Non-Small Cell Lung Cancer: Local Experience and Review of the Literature.
Clin Lung Cancer
; 23(2): e104-e115, 2022 03.
Article
in English
| MEDLINE | ID: mdl-34325996
15.
Circulating tumor DNA as a biomarker for monitoring early treatment responses of patients with advanced lung adenocarcinoma receiving immune checkpoint inhibitors.
Mol Oncol
; 15(11): 2910-2922, 2021 11.
Article
in English
| MEDLINE | ID: mdl-34449963
16.
Clinical Value of EGFR Copy Number Gain Determined by Amplicon-Based Targeted Next Generation Sequencing in Patients with EGFR-Mutated NSCLC.
Target Oncol
; 16(2): 215-226, 2021 03.
Article
in English
| MEDLINE | ID: mdl-33606136
17.
Combined osimertinib, dabrafenib and trametinib treatment for advanced non-small-cell lung cancer patients with an osimertinib-induced BRAF V600E mutation.
Lung Cancer
; 146: 358-361, 2020 08.
Article
in English
| MEDLINE | ID: mdl-32534795
18.
Relevance and Effectiveness of Molecular Tumor Board Recommendations for Patients With Non-Small-Cell Lung Cancer With Rare or Complex Mutational Profiles.
JCO Precis Oncol
; 4: 393-410, 2020 Nov.
Article
in English
| MEDLINE | ID: mdl-35050740
19.
Endogenous vascular endothelial growth factor-C expression is associated with decreased drug responsiveness in childhood acute myeloid leukemia.
Clin Cancer Res
; 14(3): 924-30, 2008 Feb 01.
Article
in English
| MEDLINE | ID: mdl-18245556
20.
Peptide microarray of pediatric acute myeloid leukemia is related to relapse and reveals involvement of DNA damage response and repair.
Oncotarget
; 10(45): 4679-4690, 2019 Jul 23.
Article
in English
| MEDLINE | ID: mdl-31384395